MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    VIT-D and Tics Movement Disorder

    N. Gemawat (Mumbai, India)

    Objective: Tics is common childhood movement disorder, with classified variants , typically begin at around 4-5 years of age but often present later at about…
  • 2018 International Congress

    High dose of levodopa and Segawa disease

    M. Taghiyeva (Baku, Azerbaijan)

    Objective: To analyze the dose-dependent effects of levodopa on the symptoms of the disease in our case. Background: In 1976, Segawa et al. reported dopa-responsive…
  • 2018 International Congress

    From Non-rechargeable to Rechargeable Technology: Insights and Management of Pallidal Deep Brain Stimulation in Dystonia after Switching to a Rechargeable Implantable Pulse Generator

    M. Wolf, A. Saryyeva, D. Schulte, J. Krauss, C. Blahak (Mannheim, Germany)

    Objective: Here, we aimed to evaluate the management of stimulation intensities after switching from NRC to RC IPG compared to previous RC-to-RC replacements. Background: Patients…
  • 2018 International Congress

    The effectiveness of deep brain stimulation in dystonia: A patient-centered approach

    H. Eggink, R. Toonen, J. van Zijl, M. van Egmond, A. Bartels, R. Brandsma, MF. Contarino, K. Peall, J M. van Dijk, DLM. Oterdoom, M. Beudel, M. Tijssen (Groningen, Netherlands)

    Objective: To systematically evaluate the effectiveness of deep brain stimulation of the Globus Pallidus internus (GPi-DBS) in dystonia on pre-operatively set functional priorities in daily…
  • 2018 International Congress

    Weight loss in STN DBS in Parkinson’s Disease? Long-term outcome of a prospective cohort at 5 years

    D. Chan, C. Chan, A. Chan, C. Lau, C. Zhu, W. Poon, V. Mok (Hong Kong, Hong Kong)

    Objective: To determine the long-term weight changes in Parkinson’s Disease (PD) after Subthalamic Nucleus (STN) Deep Brain Stimulation (DBS) treatment. Background: It is well-established that…
  • 2018 International Congress

    A Patient-Centered Decision-Making Algorithm for Deep Brain Stimulation Surgery in Parkinson’s Disease

    S. Joza, K. Yen, F. Ba, J. Miyasaki (Edmonton, AB, Canada)

    Objective: To develop a computer application with responsive design to incorporate Parkinson’s Disease (PD) patients’ expectations for Deep Brain Stimulation (DBS) surgery and present them…
  • 2018 International Congress

    Spontaneous peri-electrode edema, 7 years after subthalamic nucleus deep brain stimulation (STN-DBS) in a patient with Parkinson´s disease (PD): A case report

    O. Morsi, J. Lopez, J. Jimenez, L. Fuentes, G. Valero, A.E. Baidez, E. Andreu (Murcia, Spain)

    Objective: To describe an infrequent and late complication of STN-DBS in a patient with PD. Background: DBS is a safe procedure for patients with PD.…
  • 2018 International Congress

    The efficacy and safety of STN-DBS under general anesthesia for PD patients

    W. Chen, L. Chen (Guangzhou, China)

    Objective: This study was a comparative studies of the efficacy of bilateral subthalamic deep brain stimulation (STN-DBS) for Parkinson’s disease (PD) under general anesthesia (GA)…
  • 2018 International Congress

    Mild Cognitive Impairment in Parkinson’s Disease Before and After Deep Brain Stimulation

    A. Troster, A. Abbott, F. Ponce, H. Shill, S. Oravivattanakul, G. Moguel-Cobos, N. Salins, A. Lieberman, K. Hanson (Phoenix, AZ, USA)

    Objective: To determine rates of mild cognitive impairment in Parkinson’s disease (PD-MCI) before and after deep brain stimulation (DBS) and to identify the specific cognitive…
  • 2018 International Congress

    Urodynamic findings in a cohort of patients with SCA7 reporting lower urinary tract symptoms

    T. Uchiyama, J. Ribeiro, P. Giunti, P. Georgopoulos, M. Pakzad, R. Sakakibara, S. Kuwabara, K. Hirata, J. Panicker (Chiba, Japan)

    Objective: To evaluate the urodynamic findings in a cohort of patients with Spinocerebellar Ataxia Type 7 (SCA7) reporting lower urinary tract symptoms. Background: SCA7 is…
  • « Previous Page
  • 1
  • …
  • 54
  • 55
  • 56
  • 57
  • 58
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • Effect of marijuana on Essential Tremor: A case report
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley